Imaging Seminar Series with the Center for Alzheimer Research
Join us as we discuss the latest brain imaging research. We host an imaging seminar every month, typically the last Friday of the month, over zoom with two researchers discussing their work. Welcome!
Please join us on Zoom:
https://ki-se.zoom.us/j/66507375691?pwd=eUpwcU50cjZ5V2xqWnNWczNZM3hBQT09
Meeting ID: 665 0737 5691
Passcode: 148489
Seminars, fall 2023
August 25 at 1 pm
Milan Němý, Czech Technical University, Czech Republic and KI
"Basal Forebrain, Cholinergic White Matter Pathways and Cognition in Normal Aging and Alzheimer’s Disease"
Niels Okkels, Aarhus University, Denmark
"Cholinergic changes in the brain and abdominal organs in dementia with Lewy bodies"
September 29 at 10 am (please not the time!)
Lyduine Collij, Lund University
"Disease heterogeneity in Alzheimer’s disease: spatial-temporal subtypes in amyloid pathology based on PET imaging"
Emma Luckett, Karolinska Institutet
"Weighted gene co-expression network analysis detects changes in the peripheral blood transcriptome in asymptomatic Alzheimer’s disease"
October 27 at 1 pm
Jessica Samuelsson, University of Gothenburg, Sweden
"Associations between dietary patterns and dementia-related neuroimaging markers"
Laura Stankeviciute, BarcelonaBeta Brain Research Center, Spain
"Sleep in preclinical stages of Alzheimer's disease: A multimodal biomarkers approach"
November 24 at 1 pm
José Paredes Pacheco, University of Málaga, Spain
"An online platform for the Monte Carlo simulation of realistic brain PET data: SimPET"
Francisco Javier López, Fundación CIEN, Spain
"Quantification methods of PET biomarkers in Alzheimer’s disease"
December 15 at 1 pm
Marco Duering, Institute for Stroke and Dementia Research (ISD), Germany
Title TBA
Seminars, spring 2023
February 24 at 1 pm
Mona-Lisa Malarte, KI
"Deciphering the interplay between reactive astrogliosis and tau pathology in 4R tauopathies"
Kevin Oliveira Hauer, Lunds universitet
"Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy"
March 27 at 1 pm
Anna Inguanzo, KI
"MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies"
Han Soo Yoo, Yonsei University, Seoul, Korea
"Multitracer PET imaging to evaluate dementia with Lewy bodies (DLB)"
April 28 at 1 pm
Bárbara Avelar Pereira, KI
“Decoding the heterogeneity of Alzheimer’s disease diagnosis & progression using multilayer networks”
Anthipa Chokesuwattanaskul, Chulalongkorn University, Thailand
The architecture of abnormal reward behaviour in dementia”
May 26 at 1 pm
Miriam Scarpa, KI
“Pre-clinical validation of SV2A-PET tracer UCB-J for detecting synaptic loss in AD and PSP”
Stephen Carter, University of Cambridge
“EMIF PreclinAD: dementia biomarkers, longitudinal cognitive trajectories and brain resilience in cognitively unimpaired elderly”
June 30 at 1 pm
Alexander Kvist, KI
"Understanding complex walking in Parkinson's disease, from gait analysis to neuroimaging"
Rodrigo Vitorio, Northumbria University
"The control of walking in Parkinson's disease: illuminating mechanisms and interventions with fNIRS"
Seminars 2022
December 16 at 1 pm
Annemieke ter Telgte, VASCage, Austria
“On the origin of cerebral small vessel disease”
November 25 at 1 pm
Annegret Habich, KI
(Dis-)connected Dots in Dementia with Lewy Bodies – A Systematic Review of Connectivity Studies
Ramtin Mehraram, KU Leuven, Belgium
Lewy body dementia: EEG-network biomarkers and visual hallucinations
October 28 at 1 pm
Anna Dewenter, Institute for Stroke and Dementia Research
The effects of Alzheimer’s disease and cerebral small vessel disease on white matter fiber tracts
Nira Cedres, University Fernando Pessoa-Canarias
Association between cerebrovascular and Alzheimer's disease biomarkers and the degeneration of the cholinergic system
September 30 at 1 pm
Yuanjing Li, KI
Thalamic gray matter volume mediates the association between KIBRA polymorphism and olfactory function among older adults
Olof Lindberg, KI
Reduced blood oxygen dependent signal in the anterior cingulate cortex and the anterior insula in behavioral variant frontotemporal dementia when viewing images of hands in painful situations
August 26 at 1 pm
Marco Bucci, KI
Levels of plasma neurofilament light alone or in combination with pTau-181 predict for steeper cognitive decline in Typical AD and Hippocampal-sparing subtype but not in Limbic-predominant AD subtype
Konstantinos Chiotis, KI
Tracking reactive astrocytes in autosomal dominant Alzheimer’s disease with plasma GFAP and multi-modal PET
June 24 at 1 pm
Goran Papenberg, KI
Aging-related losses in fronto-striatal dopamine D2 receptor availability is linked to working-memory decline across five years
Alireza Salami, KI and Umeå University
Bi-phasic patterns of age-related differences in dopamine D1 receptors across the adult lifespan
May 27, at 1 pm
Einar August Høgestøl, University of Oslo
The brain age paradigm across neurodegenerative disorders
Daniel Vereb, KI
Directed connectivity networks across Alzheimer’s disease spectrum
April 29 at 1 pm
Laia Montoliu-Gaya, University of Gothenburg
Plasma and cerebrospinal fluid GFAP levels in Down syndrome and sporadic Alzheimer’s disease: a cross-sectional study
Bruno Robalo, University of Utrecht
Diffusion MRI harmonization enables joint-analysis of multicenter data of patients with cerebral small vessel disease
March 22 at 1 pm
Silvia Fanton, KI
NetPlotBrain: A Python package to easily create 3D network visualizations on a brain and its usage in pain neuroimaging
Didac Vidal Pineiro, University of Oslo
ggseg: visualization of brain statistics in R and applications in lifespan cognitive neuroscience
February 25 at 1 pm
Robin Pedersen, Umeå University
Inter-regional dopamine D1 co-variability reflects functional brain architecture
Jonatan Gustavsson, KI
Brain iron and the dopaminergic system: Links to cognition in aging
January 28 at 1 pm
Anna Canal García, KI
Multiplex connectome changes across the Alzheimer’s disease spectrum using gray matter and amyloid data
Mite Mijalkov, KI
Directed brain connectivity identifies widespread functional network changes in Parkinson’s disease